Lv563
1150 积分 2025-05-11 加入
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome
14天前
已完结
CD19-targeted CAR T cells in refractory antisynthetase syndrome
1个月前
已完结
Janus kinase inhibition (JAKi) therapy in refractory anti-synthetase syndrome: A retrospective cohort study
1个月前
已完结
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome
1个月前
已完结
Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature review
1个月前
已完结
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development
2个月前
已完结
Immune checkpoint inhibitors and rheumatoid arthritis: all roads lead to PD-1?
6个月前
已完结
Toward immune tolerance in rheumatoid arthritis: Emerging immunotherapies and targets for long-term remission
6个月前
已完结
皖公网安备34019202002308
